NCT04380558

Brief Summary

Urinary incontinence is a frequent chronic condition in general population. It is even more frequent in people with chronic respiratory disease due to several factors, including but not limited to frequent cough. Urinary incontinence may be more frequent during exercise so that it may contribute to the general deconditioning associated with chronic respiratory disease. Although pulmonary rehabilitation is a cornerstone in the management of people with chronic respiratory disease to break this spiral of worsening dyspnea, little is known about the prevalence of urinary incontinence among those people referred for pulmonary rehabilitation nor about its impact on the effects of the program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
341

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2020

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 5, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 8, 2020

Completed
3 days until next milestone

Study Start

First participant enrolled

May 11, 2020

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 26, 2024

Completed
Last Updated

March 11, 2025

Status Verified

March 1, 2025

Enrollment Period

3.6 years

First QC Date

May 5, 2020

Last Update Submit

March 7, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Prevalence of urinary incontinence symptoms

    The prevalence of urinary incontinence symptoms will be assessed using the International Consultation on Incontinence Short Form

    The questionnaire will be administered at baseline

  • Prevalence of urinary incontinence symptoms

    The prevalence of urinary incontinence symptoms will be assessed using the International Consultation on Incontinence Short Form

    The questionnaire will be administered at the end of the program (8weeks)

Secondary Outcomes (14)

  • Type of urinary incontinence symptoms

    The questionnaire will be administered at baseline

  • Type of urinary incontinence symptoms

    The questionnaire will be administered at the end of the program (8weeks)

  • Exercise capacity - Six-minute walk test (meters)

    The test will be administered at baseline

  • Exercise capacity - Six-minute walk test (meters)

    The test will be administered at the end of the program (8weeks)

  • Exercise capacity - Six-minute stepper test (steps)

    The test will be administered at baseline

  • +9 more secondary outcomes

Study Arms (1)

Prospective observational cohort

Every patient referred to pulmonary rehabilitation program will be eligible. They will will be asked to answer two questionnaires about urinary incontinence symptoms (see outcomes) to assess the prevalence and the type of these symptoms. They will subsequently participate in their usual pulmonary rehabilitation program consisting in 90min sessions (including endurance training, muscle strengthening and self-management), 3x/week for 8weeks (centre 1) or 2x60min sessions (including the same components), 3x/week for 8weeks (centre 2).

Other: Pulmonary rehabilitation

Interventions

Patients will be asked to answer two questionnaires about urinary incontinence symptoms (see outcomes) to assess the prevalence and the type of these symptoms. They will subsequently participate in their usual pulmonary rehabilitation program consisting in 90min sessions (including endurance training, muscle strengthening and self-management), 3x/week for 8weeks (centre 1) or 2x60min sessions (including the same components), 3x/week for 8weeks (centre 2).

Prospective observational cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

People reffered for pulmonary rehabilitation.

You may qualify if:

  • Age \> 18 ans ;
  • Referred for pulmonary rehabilitation ;
  • History of pathology or prostate surgery ;
  • Contra indication to pulmonary rehabilitation ;

You may not qualify if:

  • Pregnant woman or likely to be ;
  • Patient under guardianship ;
  • Patient withdrawal ;
  • Did not complete at least 18 pulmonary rehabilitation sessions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

ADIR Association

Bois-Guillaume, France

Location

Groupe Hospitalier du Havre

Le Havre, France

Location

MeSH Terms

Conditions

Urinary Incontinence

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • David Debeaumont, MD

    CHU-Hôpitaux de Rouen - Hôpital de Bois-Guillaume, Service de physiologie urinaire, digestive, respiratoire et sportive, Bois-Guillaume, France

    PRINCIPAL INVESTIGATOR
  • Antoine Cuvelier, Prof, PhD

    CHU-Hôpitaux de Rouen - Service de pneumologie, Hôpital de Bois-Guillaume, Rouen, France ; UPRES EA 3830, Institut de Recherche et d'Innovation Biomédicale de Haute-Normandie, Université de Rouen, Rouen, France.

    STUDY CHAIR
  • Tristan Bonnevie, MsC

    ADIR Association, Bois-Guillaume, France ; UPRES EA 3830, Institut de Recherche et d'Innovation Biomédicale de Haute-Normandie, Université de Rouen, Rouen, France

    STUDY CHAIR
  • Francis-Edouard Gravier, PT

    ADIR Association, Bois-Guillaume, France

    STUDY CHAIR
  • Jean-François Muir, Prof, PhD

    CHU-Hôpitaux de Rouen - Service de pneumologie, Hôpital de Bois-Guillaume, Rouen, France ; UPRES EA 3830, Institut de Recherche et d'Innovation Biomédicale de Haute-Normandie, Université de Rouen, Rouen, France ; ADIR Association, Bois-Guillaume, France

    STUDY CHAIR
  • Bouchra Lamia, Prof, PhD

    UPRES EA 3830, Institut de Recherche et d'Innovation Biomédicale de Haute-Normandie, Université de Rouen, Rouen, France ; Service de pneumologie, Hôpital Jacques Monod 76290 Montivilliers

    STUDY CHAIR
  • Jean Quieffin, MD

    Service de pneumologie, Hôpital Jacques Monod 76290 Montivilliers

    STUDY CHAIR
  • Guillaume Prieur, PT, MsC

    Service de pneumologie, Hôpital Jacques Monod 76290 Montivilliers

    STUDY CHAIR
  • Clément Médrinal, PT, MsC

    UPRES EA 3830, Institut de Recherche et d'Innovation Biomédicale de Haute-Normandie, Université de Rouen, Rouen, France. Service de réanimation, Groupe Hospitalier du Havre, France

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 5, 2020

First Posted

May 8, 2020

Study Start

May 11, 2020

Primary Completion

December 20, 2023

Study Completion

February 26, 2024

Last Updated

March 11, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations